Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uremic toxicity and anemia.

Mario Bonomini1, Vittorio Sirolli

  • 1Institute of Nephrology, Department of Medicine, G. d'Annunzio University, Chieti, Italy. m.bonomini@nephro.unich.it

Journal of Nephrology
|March 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD: Case Report and Disease Update.

Diagnostics (Basel, Switzerland)·2026
Same author

Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care.

Kidney international reports·2026
Same author

Dialysis Unit Differences in Post-Dialysis Fatigue Prevalence and Characteristics and Time to Recovery After Dialysis.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Hydrothorax as a Complication of Peritoneal Dialysis: A Case Report.

Case reports in nephrology·2025
Same author

Difelikefalin for CKD-aP: real world evidence of efficacy and safety in Italian patients.

Clinical kidney journal·2025
Same author

Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?

Cardiovascular research·2025
Same journal

Correction to: Abdominal arterial calcification profile in kidney transplant candidates: a comparison between patients with autosomal dominant polycystic kidney disease and those with other causes of kidney failure.

Journal of nephrology·2026
Same journal

Lessons for the Clinical Nephrologist. Not to see the forest for the trees: the diagnostic challenge with valproic acid-induced Fanconi-like proximal tubulopathy.

Journal of nephrology·2026
Same journal

Longitudinal trajectories in multidomain frailty among patients with chronic kidney disease.

Journal of nephrology·2026
Same journal

Correction to: Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.

Journal of nephrology·2026
Same journal

Improving eGFR estimation in diabetic populations: insights from real-world data.

Journal of nephrology·2026
Same journal

Barriers delaying treatment in cases at risk of crush syndrome in major disasters: Kahramanmaraş earthquake experience.

Journal of nephrology·2026
See all related articles

Anemia in chronic kidney disease is mainly due to poor erythropoietin production. Uremic toxicity and retention solutes may also worsen this anemia by inhibiting red blood cell production and causing hemolysis.

Area of Science:

  • Nephrology
  • Hematology
  • Toxicology

Background:

  • Anemia is a common complication of chronic renal failure (CRF).
  • Inappropriate erythropoietin production is the primary cause of CRF anemia.
  • Other contributing factors, including uremic toxins, are under investigation.

Purpose of the Study:

  • To investigate the role of uremic toxicity in exacerbating anemia in chronic renal failure.
  • To explore the contribution of uremic retention solutes to the pathogenesis of CRF anemia.

Main Methods:

  • Review of existing literature on uremic toxicity and anemia in chronic renal failure.
  • Analysis of studies supporting the presence of erythropoiesis inhibitors and hemolysins in uremic serum.

Main Results:

Related Experiment Videos

  • Evidence suggests that substances in uremic serum can inhibit erythropoiesis and cause hemolysis.
  • The exact contribution of uremic retention solutes to anemia pathogenesis remains debated.

Conclusions:

  • Uremic toxicity plays a significant role in worsening anemia associated with chronic renal failure.
  • Further research is needed to fully elucidate the mechanisms by which uremic solutes affect red blood cell production and survival.